UnitedHealth Group reported quarterly results ahead of consensus, with revenue 12.3% above Street estimates. Management raised forward guidance, citing broad-based demand strength.
Loading…
Live wire — catalyst-driven headlines and macro news as they publish.
Flagged as breaking
UnitedHealth Group reported quarterly results ahead of consensus, with revenue 12.3% above Street estimates. Management raised forward guidance, citing broad-based demand strength.
CVS Health Corporation updated its full-year outlook in an investor update, citing current order trends and visibility into the back half of the fiscal year.
Elevated short interest combined with a spike in volume has raised the odds of a squeeze-driven move; borrow rates on the name have risen sharply this week.
ConocoPhillips announced a definitive agreement expected to close within two to three quarters, pending regulatory approval. The deal is structured as a mix of cash and stock consideration.
L3Harris Technologies confirmed the award in a regulatory filing, citing backlog growth and improved multi-year revenue visibility. Terms include phased delivery milestones over the contract period.
Devon Energy Corporation confirmed the award in a regulatory filing, citing backlog growth and improved multi-year revenue visibility. Terms include phased delivery milestones over the contract period.
Coinbase Global, Inc. confirmed the regulatory development in a public filing, and management is assessing downstream effects on its operating plan.
Oklo Inc. confirmed the regulatory development in a public filing, and management is assessing downstream effects on its operating plan.
NKE formally launched the product at an industry event, with general availability targeted for the coming quarter. Early partner feedback and pricing details were disclosed alongside the announcement.
Microsoft Corporation reported quarterly results ahead of consensus, with revenue 9.9% above Street estimates. Management raised forward guidance, citing broad-based demand strength.
MARA Holdings, Inc. confirmed the regulatory development in a public filing, and management is assessing downstream effects on its operating plan.
Nonfarm payrolls came in above consensus, pushing yields higher across the curve and weighing on rate-sensitive sectors in early trading.
The Federal Reserve left its benchmark rate unchanged, with the statement reiterating a data-dependent approach to future moves. Futures markets modestly trimmed the odds of a near-term cut following the release.
All headlines, newest first
UnitedHealth Group reported quarterly results ahead of consensus, with revenue 12.3% above Street estimates. Management raised forward guidance, citing broad-based demand strength.
CVS Health Corporation updated its full-year outlook in an investor update, citing current order trends and visibility into the back half of the fiscal year.
Elevated short interest combined with a spike in volume has raised the odds of a squeeze-driven move; borrow rates on the name have risen sharply this week.
ConocoPhillips announced a definitive agreement expected to close within two to three quarters, pending regulatory approval. The deal is structured as a mix of cash and stock consideration.
L3Harris Technologies confirmed the award in a regulatory filing, citing backlog growth and improved multi-year revenue visibility. Terms include phased delivery milestones over the contract period.
Devon Energy Corporation confirmed the award in a regulatory filing, citing backlog growth and improved multi-year revenue visibility. Terms include phased delivery milestones over the contract period.
Coinbase Global, Inc. confirmed the regulatory development in a public filing, and management is assessing downstream effects on its operating plan.
Oklo Inc. confirmed the regulatory development in a public filing, and management is assessing downstream effects on its operating plan.
NKE formally launched the product at an industry event, with general availability targeted for the coming quarter. Early partner feedback and pricing details were disclosed alongside the announcement.
Microsoft Corporation reported quarterly results ahead of consensus, with revenue 9.9% above Street estimates. Management raised forward guidance, citing broad-based demand strength.
MARA Holdings, Inc. confirmed the regulatory development in a public filing, and management is assessing downstream effects on its operating plan.
The latest CPI print showed core inflation decelerating for a third consecutive month, giving markets more confidence in a soft-landing scenario.
TSLA formally launched the product at an industry event, with general availability targeted for the coming quarter. Early partner feedback and pricing details were disclosed alongside the announcement.
Market breadth narrowed again this session, with mega-cap technology names accounting for the bulk of index-level gains while small caps underperformed.
Nonfarm payrolls came in above consensus, pushing yields higher across the curve and weighing on rate-sensitive sectors in early trading.
Huntington Ingalls Industries confirmed the award in a regulatory filing, citing backlog growth and improved multi-year revenue visibility. Terms include phased delivery milestones over the contract period.
AMZN formally launched the product at an industry event, with general availability targeted for the coming quarter. Early partner feedback and pricing details were disclosed alongside the announcement.
The Federal Reserve left its benchmark rate unchanged, with the statement reiterating a data-dependent approach to future moves. Futures markets modestly trimmed the odds of a near-term cut following the release.
Oracle Corporation reported quarterly results ahead of consensus, with revenue 5.2% above Street estimates. Management raised forward guidance, citing broad-based demand strength.
West Texas Intermediate fell after weekly inventory data showed a larger-than-expected build, adding to concerns about softening global demand.
The FDA approval covers an expanded adult population, based on pivotal trial data submitted in the company's application. NVAX plans a commercial launch and has flagged peak sales estimates in upcoming investor materials.
The FDA approval covers an expanded adult population, based on pivotal trial data submitted in the company's application. REGN plans a commercial launch and has flagged peak sales estimates in upcoming investor materials.
Cameco Corporation confirmed the regulatory development in a public filing, and management is assessing downstream effects on its operating plan.
Starbucks Corporation reported quarterly EPS 5% below Street estimates and issued next-quarter guidance under consensus, citing macro headwinds and softer demand in key end markets.
A widely watched consumer sentiment gauge topped forecasts, driven by an improved outlook on household income over the next twelve months.
Chipmakers rallied broadly after several large-cap technology names reiterated elevated AI infrastructure spending plans for the coming year.
Space Force selected Uranium Energy Corp. (UEC) for a multi-year program covering delivery, sustainment, and technical support. The award follows a competitive bid process; management expects revenue recognition to begin next fiscal quarter.
The dollar held in a narrow range ahead of a scheduled speech from a Federal Reserve official, with cross-asset volatility remaining subdued.
The upgrade cites improving fundamentals and a more favorable risk/reward setup heading into the next several quarters.
Newmont Corporation reported quarterly EPS 18% below Street estimates and issued next-quarter guidance under consensus, citing macro headwinds and softer demand in key end markets.
NuScale Power Corporation confirmed the award in a regulatory filing, citing backlog growth and improved multi-year revenue visibility. Terms include phased delivery milestones over the contract period.
The Boeing Company confirmed the award in a regulatory filing, citing backlog growth and improved multi-year revenue visibility. Terms include phased delivery milestones over the contract period.
Biogen Inc. confirmed the regulatory development in a public filing, and management is assessing downstream effects on its operating plan.
Target Corporation reported quarterly results ahead of consensus, with revenue 3% above Street estimates. Management raised forward guidance, citing broad-based demand strength.
Kratos Defense & Security Solutions confirmed the regulatory development in a public filing, and management is assessing downstream effects on its operating plan.
Verizon Communications confirmed the regulatory development in a public filing, and management is assessing downstream effects on its operating plan.
Exxon Mobil Corporation confirmed the regulatory development in a public filing, and management is assessing downstream effects on its operating plan.
A Form 4 filing shows the transaction was executed on the open market. Insider buying of this size is being read by some desks as a confidence signal ahead of the next catalyst window.
Lockheed Martin Corporation confirmed the regulatory development in a public filing, and management is assessing downstream effects on its operating plan.
Meta Platforms, Inc. reported quarterly EPS 22% below Street estimates and issued next-quarter guidance under consensus, citing macro headwinds and softer demand in key end markets.
Intel Corporation reported quarterly results ahead of consensus, with revenue 7.3% above Street estimates. Management raised forward guidance, citing broad-based demand strength.
Palantir Technologies updated its full-year outlook in an investor update, citing current order trends and visibility into the back half of the fiscal year.
Chevron Corporation updated its full-year outlook in an investor update, citing current order trends and visibility into the back half of the fiscal year.
Freeport-McMoRan Inc. confirmed the award in a regulatory filing, citing backlog growth and improved multi-year revenue visibility. Terms include phased delivery milestones over the contract period.
Netflix, Inc. reported quarterly results ahead of consensus, with revenue 9.6% above Street estimates. Management raised forward guidance, citing broad-based demand strength.
Advanced Micro Devices updated its full-year outlook in an investor update, citing current order trends and visibility into the back half of the fiscal year.
Vertex Pharmaceuticals reported topline data from its Phase 1 study. The company said it will present full results at an upcoming medical conference and discuss next regulatory steps with the FDA.
GM formally launched the product at an industry event, with general availability targeted for the coming quarter. Early partner feedback and pricing details were disclosed alongside the announcement.
Occidental Petroleum announced a definitive agreement expected to close within two to three quarters, pending regulatory approval. The deal is structured as a mix of cash and stock consideration.
Broadcom Inc. reported quarterly results ahead of consensus, with revenue 13.6% above Street estimates. Management raised forward guidance, citing broad-based demand strength.
GE Aerospace confirmed the award in a regulatory filing, citing backlog growth and improved multi-year revenue visibility. Terms include phased delivery milestones over the contract period.
Riot Platforms, Inc. confirmed the regulatory development in a public filing, and management is assessing downstream effects on its operating plan.
The upgrade cites improving fundamentals and a more favorable risk/reward setup heading into the next several quarters.
Moderna, Inc. confirmed the regulatory development in a public filing, and management is assessing downstream effects on its operating plan.
Snowflake Inc. said the multi-year partnership will combine both companies' technology stacks, with joint go-to-market efforts expected to begin this fiscal year.
F formally launched the product at an industry event, with general availability targeted for the coming quarter. Early partner feedback and pricing details were disclosed alongside the announcement.